Proliferative activity in stenotic human aortocoronary bypass grafts

Cardiovascular Pathology

Volumn 11, Issue 5, 2002, Pages 284-290

  Hilker, Michael ^a   Tellmann, Gudrun ^a   Buerke, Michael ^a   Gloger, Karin ^a   Moersig, Wolfgang ^a   Oelert, Helmut ^a   Hake, Ulrich ^a   Lehr, Hans Anton ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Bypass graft disease; Proliferation; Veins

Indexed keywords

ALPHA ACTIN; ANTIBODY; CD31 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; KI 67 ANTIGEN;

ADVENTITIA; ARTICLE; BLOOD VESSEL WALL; CELL COUNT; CELL LABELING; CELL PROLIFERATION; CELL TYPE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENDOTHELIUM CELL; EXPLANT; FEMALE; GRAFT FAILURE; GRAFT OCCLUSION; HEART SURGERY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFLAMMATION; INTIMA; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SAPHENOUS VEIN GRAFT; SMOOTH MUSCLE FIBER; STENOSIS; T CELL LYMPHOMA; VEIN GRAFT;

ACTINS; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL COUNT; CELL DIVISION; CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; REOPERATION; SAPHENOUS VEIN; T-LYMPHOCYTES;

EID: 0036754660     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(02)00113-8     Document Type: Article

References (38)

1. Cooper G.J., Underwood M.J., Deverall P.B. Arterial and venous conduits for coronary artery bypass. A current review. Eur J Cardio-thorac Surg. 10:1996;129-140.
2. Motwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 97:1998;916-931.
3. Bulkley B.H., Hutchins G.M. Accelerated "atherosclerosis." A morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation. 55:1977;163-169.
4. Atkinson J.B., Forman M.B., Vaughn W.K., Robinowitz M., McAllister H.A., Virmani R. Morphologic changes in long-term saphenous vein bypass grafts. Chest. 88:1985;341-348.
5. Brody J.I., Pickering N.J., Fink G.B. Immunocytochemical features of obstructed saphenous vein coronary artery bypass grafts. J Clin Pathol. 42:1989;477-482.
6. Gibbons G.H., Dzau V.J. The emerging concept of vascular remodeling. N Engl J Med. 330:1994;1431-1438.
7. Gibbons G.H. The pathogenesis of graft vascular disease: implications of vascular remodeling. J Heart Lung Transplant. 14:1995;S149-S158.
8. Meng X., Mavromatis K., Galis Z.S. Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair. Exp Mol Pathol. 66:1999;227-237.
9. Eritsland J., Arnesen H., Fjeld N.B., Gronseth K., Abdelnoor M. Risk factors for graft occlusion after coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg. 29:1995;63-69.
10. Newby A.C., George S.J. Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr Opin Cardiol. 11:1996;574-582.
11. Brandl R., Richter T., Haug K., Wilhelm M.G., Maurer P.C., Nathrath W. Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation. 96:1997;3360-3368.
12. O'Brien E.R., Alpers C.E., Stewart DKet al. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res. 73:1993;223-231.
13. Zou Y., Dietrich H., Hu Y., Metzler B., Wick G., Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol. 153:1998;1301-1310.
14. Pickering J.G., Weir L., Jekanowski J., Kearney M.A., Isner J.M. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest. 91:1993;1469-1480.
15. Lehr H.A., Hansen D.A., Kussick Set al. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol. 30:1999;1314-1320.
16. Gordon D., Reidy M.A., Benditt E.P., Schwartz S.M. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA. 87:1990;4600-4604.
17. Westerband A., Mills J.L., Marek J.M., Heimark R.L., Hunter G.C., Williams S.K. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses. J Vasc Surg. 25:1997;64-73.
18. Clowes A.W., Clowes M.M. Kinetics of cellular proliferation after arterial injury: IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res. 58:1986;839-845.
19. Scott R.J., Hall P.A., Haldane JSet al. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol. 165:1991;173-178.
20. Mills C.J., Northrup J.L., Hullinger T.G., Simmons C.A., Shebuski R.J., Jones D.A. Temporal expression of c-fos mRNA following balloon injury in the rat common carotid artery. Cardiovasc Res. 32:1996;954-961.
21. Powell J.T., Gosling M. Molecular and cellular changes in vein grafts: influence of pulsatile stretch. Curr Opin Cardiol. 13:1998;453-458.
22. Schwartz S.M., Campbell G.R., Campbell J.H. Replication of smooth muscle cells in vascular disease. Circ Res. 58:1986;427-444.
23. Shi Y., O'Brien J.E., Mannion JDet al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation. 95:1997;2684-2693.
24. Newby A.C. Molecular and cell biology of native coronary and vein-graft atherosclerosis: regulation of plaque stability and vessel-wall remodelling by growth factors and cell-extracellular matrix interactions. Coron Artery Dis. 8:1997;213-224.
25. Powell R.J., Carruth J.A., Basson M.D., Bloodgood R., Sumpio B.E. Matrix-specific effect of endothelial control of smooth muscle cell migration. J Vasc Surg. 24:1996;51-57.
26. Westerband A., Mills J.L., Hunter G.C., Gentile A.T., Ihnat D., Heimark R.L. Topography of cell replication in human vein graft stenoses. Circulation. 98:1998;II325-II329. discussion II329-30.
27. Gerrity R.G. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 103:1981;181-190.
28. Watanabe T., Hirata M., Yoshikawa Y., Nagafuchi Y., Toyoshima H., Watanabe T. Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab Invest. 53:1985;80-90.
29. Amano J., Suzuki A., Sunamori M., Tsukada T., Numano F. Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months. Am J Cardiol. 67:1991;1234-1236.
30. Barger A.C., Beeuwkes R., Lainey L.L., Silverman K. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med. 310:1984;175-177.
31. Zamir M., Silver M.D. Vasculature in the wall of coronary arteries. Arch Pathol Lab Med. 109:1985;659-662.
32. Rekhter M.D., Nicholls S.C., Ferguson M., Sordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb. 1993;609-617.
33. O'Brien E.R., Garvin M.R., Dev Ret al. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol. 145:1994;883-894.
34. George S.J., Williams A., Newby A.C. An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro. Atherosclerosis. 120:1996;227-240.
35. Kuzuya M., Satake S., Esaki Tet al. Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque. J Cell Physiol. 164:1995;658-667.
36. Lee M., Simon A.D., Stein C.A., Rabbani L.E. Antisense strategies to inhibit restenosis. Antisense Nucleic Acid Drug Dev. 9:1999;487-492.
37. Mann M.J., Gibbons G.H., Tsao PSet al. Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts. J Clin Invest. 99:1997;1295-1301.
38. Newby A.C., Baker A.H. Targets for gene therapy of vein grafts. Curr Opin Cardiol. 14:1999;489-494.